Dynamics of cytokine generation in patients with active pulmonary tuberculosis

Current Opinion in Infectious Diseases

Volumn 16, Issue 3, 2003, Pages 205-210

  Jo, Eun Kyeong ^a   Park, Jeong Kyu ^a   Dockrell, Hazel M ^b  

^a Chungnam National University   (South Korea)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Active pulmonary tuberculosis; Interferon gamma; Interleukin 12; Interleukin 18; Interleukin 4; Mycobacterial antigen

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; MYCOBACTERIUM ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT CHEMOTHERAPY; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOLECULAR DYNAMICS; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROPHYLAXIS; PROTECTION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0037607230     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200306000-00004     Document Type: Review

References (52)

1. World Health Organization. STOP TB. Geneva: World Health Organization; 2001.
2. World Health Organization. The world health report. Geneva: World Health Organization; 2000.
3. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-γ receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335:1941-1949.
4. Tsao TO, Huang CO, Chiou WK, et al. Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 6:720-727.
5. Burgess LJ, Reuter H, Carstens ME, et al. Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis 2002; 6:439-446.
6. Tsao TO, Chen OH, Hong JH, et al. Shifts of T4/T8 T lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis. Chest 2002; 122:1285-1291.
7. Vankayalapati R, Wizel B, Weis SE, et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003; 36:24-28. This study showed that serum concentrations of interferon-γ, and interleukins 18 and 10 do not parallel M. tuberculosis-induced cytokine levels by PBMCs and emphasized the role of interleukin-10 in depressed interferon-γ production in tuberculosis patients in response to mycobacterial antigens.
8. Ribeiro-Rodrigues R, Resende Co T, Johnson JL, et al. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol 2002; 9:818-823. This study showed markedly elevated concentrations of interferon-γ in sputum from tuberculosis patients over those in healthy control groups decreased rapidly with anti-tuberculosis therapy, implicating that sputum cytokines may serve as potential early markers for sputum conversion and response to anti-tuberculosis therapy.
9. Lienhardt C, Azzurri A, Amedei A, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002; 32:1605-1613. These authors used serological markers associated with Th1 or Th2 responses in a large scale study that documented that before treatment, patients with tuberculosis have increased concentrations of serum markers of Th2 responses, that fall with successful therapy.
10. Barnes PF, Wizel B. Type 1 cytokines and the pathogenesis of tuberculosis. Am J Respir Crit Care Med 2000; 161:1773-1774.
11. Song CH, Kim HJ, Park JK, et al. Depressed IL-12, but not IL-18 production in response to a 30- and 32-kDa mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun 2000; 68:4477-4484.
12. Jo EK, Kim HJ, Min D, et al. Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis. Scand J Immunol 2000; 51:209-217.
13. Dieli F, Friscia G, Di Sano C, et al. Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J Infect Dis 1999; 180:225-228.
14. Cardoso FL, Antas PR, Milagres AS, et al. T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients. Infect Immun 2002; 70:6707-6714. Although ESAT-6 is generally described as M. tuberculosis-specific, this study in tuberculosis patients, leprosy patients and controls showed that it may have limitations in areas endemic for tuberculosis.
15. Hussain R, Kaleem A, Shahid F, et al. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 2002; 264:95-108. This study used a simple diluted whole blood assay to demonstrate increased production of pro-inflammatory cytokines in tuberculosis patients compared with healthy endemic controls.
16. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183:469-477.
17. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 69:6554-6557.
18. Seah GT, Scott GM, Rook GAW. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181:385-389.
19. + T cells also show reduced interferon-γ production and increased interleukin-4 production during active tuberculosis.
20. Sharma SK, Mitra DK, Balamurugan A, et al. Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 2002; 22:345-352.
21. Jung YJ, LaCourse R, Ryan L, et al. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect Immun 2002; 70:6436-6443. Mice unable to make interleukins 4 or 13 control infection with M. tuberculosis as well as wild-type controls, suggesting that in this mouse model at least, Th2 cell activation does not prevent beneficial Th1 cells from controlling infection.
22. Hirsch CS, Toossi Z, Vanham G, et al. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis 1999; 179:945-953.
23. Lee JS, Song CH, Kim CH, et al. Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol 2002; 128:516-524. This study showed that HIV-negative MDR-tuberculosis patients have dysregulated interleukin 12, 18 and 10, as well as depressed inteferon-γ production, and that their cytokine profiles are similar to those in patients with drug-sensitive advanced tuberculosis as previously reported in the literature.
24. Garcia M, Vargas JA, Castejon R, et al. Flow-cytometric assesment of lymphocyte cytokine production in tuberculosis. Tuberculosis 2002; 82:37-41.
25. Boussiotis VA, Tsai EY, Yunis EJ, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105:1317-1325.
26. Samten B, Ghosh P, Yi AK, et al. Reduced expression of nuclear cyclic adenosine 5′-monophosphate response element-binding proteins and IFN-gamma promoter function in disease due to an intracellular pathogen. J Immunol 2002; 168:3520-3526. This study showed that reduced expression of CREB nuclear proteins in tuberculosis patients results in decreased interferon-γ promoter activity, suggesting an underlying mechanism of the reduced interferon-γ production in tuberculosis patients.
27. Dieli F, Friscia G, Di Sano C, et al. Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J Infect Dis 1999; 180:225-228.
28. Hirsch CS, Toossi Z, Othieno C, et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999; 180:2069-2073.
29. Delgado JC, Tsai EY, Thim S, et al. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci U S A 2002; 99:7576-7581. This large-scale study showed that anergy to PPD is antigen-specific and persistent in a subset of pulmonary tuberculosis patients and is characterized by antigen-specific impaired T cell proliferative responses and a distinct cytokine pattern.
30. Altare F, Lammas D, Revy P, et al. Inherited interleukin-12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 1998; 102:2035-2040.
31. Frucht DM, Holland SM. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J Immunol 1996; 157:411-416.
32. Verhagen CE, de Boer T, Smits HH, et al. Residual type 1 immunity in patients genetically deficient for intedeukin-12 receptor beta1 (IL-12Rbeta1). Evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells. J Exp Med 2000; 192:517-528.
33. Sakai T, Matsuoka M, Aoki M, et al. Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 2001; 97:2688-2694.
34. Aksu G, Tirpan C, Cavusoglu C, et al. Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. Pediatr Infect Dis J 2001; 20:551-553.
35. Altare F, Ensser A, Breiman A, et al. Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis 2001; 184:231-236.
36. Fenhalls G, Stevens L, Bezuidenhout J, et al. Distribution of IFN-gamma, IL-4 and TNF-alpha protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas. Immunology 2002; 105:325-335. The cytokine associations with each other and with caseous necrosis are examined at the site of lung granulomas, and two major associations - interferon-γ and interleukin-12, TNF-α and caseous necrosis - are identified.
37. Wagner D, Sangari FJ, Kim S, et al. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo. J Leukoc Biol 2002; 71:80-88. This study showed that M. avium infection of macrophages inhibits interleukin-12 production by infected cells and that the suppression is not reversed by treatment with anti-interleukin-10 and anti-transforming growth factor-β1 neutralizing antibodies.
38. Lee JS, Song CH, Kim CH. et al. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients. Med Microbiol Immunol [online first]; DOI 10.1007/s00430-002-0117-2. Oct 31,2002; http://link.springer.de/link/service/journals/00430/contents/02/00117/. Patients with recurrent tuberculosis show the most significant interleukin-12 depression among the various clinical groups of tuberculosis patients and healthy controls after in-vitro stimulation with PPD or 30 kDa antigen.
39. Vankayalapati R, Wizel B, Weis SE, et al. Production of interleukin-18 in human tuberculosis. J Infect Dis 2000; 182:234-239.
40. Garcia VE, Uyemura K, Sieling PA, et al. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol 1999; 162:6114-6121.
41. Song CH, Lee JS, Nam HH, et al. IL-18 production in human pulmonary and pleural tuberculosis. Scand J Immunol 2002; 56:611-618. Interleukin-18 is elevated in PBMCs from chronic tuberculosis patients, as well as in pleural effusion from tuberculous pleurisy patients.
42. Verreck FA, de Boer T, Hoeve M, et al. Human host defense and cytokines in mycobacterial infectious diseases: interleukin-18 cannot compensate for genetic defects in the interleukin-12 system. Clin Infect Dis 2002; 35:210-212. These findings indicate that the interleukin-18/receptor system cannot substitute for defects in the interleukim-12/receptor system.
43. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345:1098-1104.
44. Mayordomo L, Marenco JL, Gomez-Mateos J, Rejon E. Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol 2002; 31:44-45.
45. Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 1988; 57:505-518.
46. Bekker LG, Maartens G, Steyn L, Kaplan G. Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis 1998; 178:580-584.
47. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
48. Portales-Perez DP, Baranda L, Layseca E, et al. Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients. Clin Diagn Lab Immunol 2002; 9:299-307.
49. + T cells in HLA-transgenic mice and humans. J Immunol 2000; 165:6463-6471.
50. + T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect Immun 1999; 68:7144-7148.
51. Dieli F, Sireci G, Caccamo N, et al. Selective depression of interferon-gamma and granulysin production with increase of proliferative response by vγg/Vδ2 T cells in children with tuberculosis. J Infect Dis 2002; 186:1835-1839. This study presented disease-associated changes in the effector functions of vγ9/Vδ2 T cells in TB patients, implicating a protective role of these T cells in immune response against M. tuberculosis infection.
52. Giacomini E, Iona E, Ferroni L, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001; 166:7033-7041.